Assessment of ovarian reserve using serum AMH levels in patients after gynecologic surgery and chemotherapy for breast cancer

Assessment of ovarian reserve using serum AMH levels in patients after gynecologic surgery and chemotherapy for breast cancer - Ovarian reserve evaluation in gynecologic conditions

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000019369

Enrollment

Registered

2015-10-15

Start date

2009-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

endometrioma

Interventions

Measurement of serum AMH levels one month before surgery and 1,12 months after surgery

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: > 4-cm endometrioma at one side at least

Exclusion criteria

Exclusion criteria: possible ovarian cancer

Design outcomes

Primary

Measure	Time frame
serum AMH levels one month before treatment, and 1,12 months afer treatment	—

Countries

Japan

Contacts

Public ContactAkira Iwase

Nagoya University School of Medicine Obstetrics and Gynecology

akiwase@med.nagoya-u.ac.jp052-744-2261

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026